For more than 100 years, Alzheimer’s disease has been treated as a one‑way descent, a diagnosis that could be delayed at best but never truly undone. Now a new wave of research in animals is ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice.  Researchers ...

Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...

Researchers showed that a severe drop in NAD+—a core energy molecule—drives Alzheimer’s pathology in both human brains and mouse models.

The medication restored normal NAD+ levels and fully reversed cognitive function in advanced Alzheimer's models.

University of Nebraska Medical Center researchers' novel mouse model of Alzheimer’s disease enables study of how human-like immune system interacts with disease This opens the door to studying how ...

Scientists at UC San Francisco and at Gladstone Institutes have identified a combination of two anticancer drugs that the researchers suggest may reverse the changes that occur in the brain during ...

In animal studies, keeping brain NAD + levels in balance prevented Alzheimer’s from developing. Even more striking, restoring NAD + balance after the disease was already advanced allowed the brain to ...